Somerset Low-Dose Emsam Does Not Need Dietary Restrictions, Committee Says
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA’s Psychopharmacologic Drugs Advisory Committee votes that 20 mg monoamine oxidase inhibitor patch can be marketed without dietary restrictions even if higher dosage strengths of Emsam require them.
You may also be interested in...
Emsam Antidepressant Patch Approved; April Launch Anticipated
Bristol/Somerset’s product avoids MAOI-class dietary restrictions at the lowest dose.
Emsam Antidepressant Patch Approved; April Launch Anticipated
Bristol/Somerset’s product avoids MAOI-class dietary restrictions at the lowest dose.
Somerset's Low-Dose Emsam Patch Needs Dietary Restrictions, FDA Reviewer Says
Dietary restrictions for the 20 mg patch of the therapy for major depressive disorder will be reviewed by the Psychopharmacologic Drugs Advisory Committee on Oct. 26.